Rakovina Therapeutics Inc. (RKVTF)
OTCMKTS · Delayed Price · Currency is USD
0.3149
-0.0139 (-4.23%)
At close: Sep 5, 2025
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of $6.73 million as of September 5, 2025. Its market cap has increased by 6.95% in one year.
Market Cap
6.73M
Enterprise Value
7.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.31
Market Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 11.84M to 6.73M, a decrease of -43.16%. That is a compound annual growth rate of -11.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 6.73M | -63.74% |
| Dec 31, 2024 | 18.55M | 311.27% |
| Dec 29, 2023 | 4.51M | -51.33% |
| Dec 29, 2022 | 9.27M | -23.63% |
| Dec 31, 2021 | 12.14M | 2.54% |
| Apr 1, 2021 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.00M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |